Finch Therapeutics Group

-$0.27 (-2.09%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FNCH and other stocks, options, and ETFs commission-free!

About FNCH

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms.

CEO
Mark Smith
Employees
131,000
Headquarters
Somerville, Massachusetts
Founded
2017

FNCH Key Statistics

Market Cap
619.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
53.31K
High Today
$13.63
Low Today
$12.50
Open Price
$13.00
Volume
59.18K
52 Week High
$22.50
52 Week Low
$12.50

FNCH Earnings

Q1 FY21
Estimated
— per share
Actual
Expected May 18, Pre-Market

You May Also Like

WIT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure